Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



PERRY MATTHEW D Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2023 4 PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns: Granted 10,967 options to buy @ $21.39, valued at $234.6k
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2020 4 PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns: Bought 200,000 shares @ $25, valued at $5M
05/27/2020 4 PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns: Granted 6,152 options to buy @ $21.27, valued at $130.9k
05/20/2019 4 PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns: Granted 120,000 options to buy @ $0.8411, valued at $100.9k
05/20/2019 4 PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns: Granted 8,167 options to buy @ $15.59, valued at $127.3k
05/21/2018 4 PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns: Granted 5,052 options to buy @ $25.16, valued at $127.1k
05/21/2018 4 PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns: Granted 60,000 options to buy @ $4.61, valued at $276.6k
05/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/03/2016 4 PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns: Granted 347,360 options to buy @ $0
01/13/2016 4 PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns: Granted 84,034 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy